Paper42707331
A real-world, multi-center, prospective, observational study for paroxysmal nocturnal haemoglobinuria (PNH) in China: Baseline characteristics, disease burden and treatment patterns.
Han B and 11 others. Ther Adv Hematol, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. A real-world, multi-center, prospective, observational study for paroxysmal nocturnal haemoglobinuria (PNH) in China: Baseline characteristics, disease burden and treatment patterns. Papers, record 42707331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42707331
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A real-world, multi-center, prospective, observational study for paroxysmal nocturnal haemoglobinuria (PNH) in China: Baseline characteristics, disease burden and treatment patterns.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06154512 | A Real-world, Multi-center, Prospective, Observational Study for PNH in China | Derived from the trial | Yes |
Source ClinicalTrials.gov
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38715220 | Advances in research on renal injury in paroxysmal nocturnal hemoglobinuria. | J Investig Med | 2024 | https://conductscience.org/library/papers/38715220 | PubMed |
| 2 | 30242915 | How we treat paroxysmal nocturnal hemoglobinuria: A consensus statement of the Canadian PNH Network and review of the national registry. | Eur J Haematol | 2019 | https://conductscience.org/library/papers/30242915 | PubMed |
| 3 | 38071133 | Paroxysmal nocturnal hemoglobinuria: Review of the patient experience and treatment landscape. | Blood Rev | 2024 | https://conductscience.org/library/papers/38071133 | PubMed |
| 4 | 30976687 | Appropriateness of red blood cell use in China in the last thirteen years: A systematic review. | Heliyon | 2019 | https://conductscience.org/library/papers/30976687 | PubMed |
| 5 | 39596172 | Thrombosis in Paroxysmal Nocturnal Hemoglobinuria (PNH): From Pathogenesis to Treatment. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39596172 | PubMed |
| 6 | 21460245 | Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. | Blood | 2011 | https://conductscience.org/library/papers/21460245 | PubMed |
| 7 | 27059871 | A comparative analysis of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria between Asia and Europe/America. | Int J Hematol | 2016 | https://conductscience.org/library/papers/27059871 | PubMed |
| 8 | 23271156 | Clinical roundtable monograph: Paroxysmal nocturnal hemoglobinuria: a case-based discussion. | Clin Adv Hematol Oncol | 2012 | https://conductscience.org/library/papers/23271156 | PubMed |
| 9 | 35390189 | Effect of eculizumab treatment in patients with paroxysmal nocturnal hemoglobinuria with or without high disease activity: Real-world findings from the International Paroxysmal Nocturnal Hemoglobinuria Registry. | Eur J Haematol | 2022 | https://conductscience.org/library/papers/35390189 | PubMed |
| 10 | 35068377 | Clinical characteristics of 512 eculizumab-naive paroxysmal nocturnal hemoglobinuria patients in China: a single-center observational study. | Hematology | 2022 | https://conductscience.org/library/papers/35068377 | PubMed |
| 11 | 32390114 | Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry. | Ann Hematol | 2020 | https://conductscience.org/library/papers/32390114 | PubMed |
| 12 | 39882598 | Eculizumab treatment for Chinese patients with hemolytic paroxysmal nocturnal hemoglobinuria (PNH): efficacy and safety - a single-center study. | Hematology | 2025 | https://conductscience.org/library/papers/39882598 | PubMed |
| 13 | 29486674 | Renal involvement in paroxysmal nocturnal hemoglobinuria: an update on clinical features, pathophysiology and treatment. | Hematology | 2018 | https://conductscience.org/library/papers/29486674 | PubMed |
| 14 | 28516949 | Paroxysmal nocturnal haemoglobinuria. | Nat Rev Dis Primers | 2017 | https://conductscience.org/library/papers/28516949 | PubMed |
| 15 | 34355382 | How we('ll) treat paroxysmal nocturnal haemoglobinuria: diving into the future. | Br J Haematol | 2022 | https://conductscience.org/library/papers/34355382 | PubMed |
| 16 | 18064739 | The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. | Lancet | 2007 | https://conductscience.org/library/papers/18064739 | PubMed |
| 17 | 20658586 | Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria. | Am J Hematol | 2010 | https://conductscience.org/library/papers/20658586 | PubMed |
| 18 | 38442722 | Impact of Lactate Dehydrogenase and Hemoglobin Levels on Clinical Outcomes in Patients With Paroxysmal Nocturnal Hemoglobinuria: Results From the National Korean PNH Registry. | J Korean Med Sci | 2024 | https://conductscience.org/library/papers/38442722 | PubMed |
| 19 | 38247114 | Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline. | Br J Haematol | 2024 | https://conductscience.org/library/papers/38247114 | PubMed |
| 20 | 27913482 | Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuria. | Hematology Am Soc Hematol Educ Program | 2016 | https://conductscience.org/library/papers/27913482 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42707331
GET https://conductscience.org/api/papers/v1/42707331/references?page=2